More than 15 years of success igniting growth for (real-world) data and AI businesses in life sciences and healthcare. Leadership roles with 'tip of the spear' innovators, including in real-world data (incl. Roche, White House - CTO HHS) and AI (Gesund.ai, Caresyntax), with a focus on turning raw innovation into products, partnerships, and businesses in regulated markets. As a passionate and successful growth architect and ecosystem builder, I thrive at Strategic Deal Making & Negotiations, (M&A, Partnerships). I also enjoy leading and aligning engineering/ business/ clinical/ data science teams. Extensive track record partnering with regulators and standard-setting bodies (e.g. FDA, HHS, NCCN, CHAI).Gesund.ai is pioneering the testing, evaluation, and monitoring of AI models (risks, performance) for pharma and medical device companies. Built a new blueprint for increasing speed AND rigor in AI development and validation, as well as for eliminating friction involved in collaborating across disciplines and organizations.I am leading commercial growth, regulatory engagement, and strategic partnerships of this pioneering platform with data partners and its network of annotators. Gesund.ai was selected to the CancerX Accelerator's first cohort and selected to the CB Insights AI 100 ('the 100 hottest AI companies in the world') in 2024.I enjoy giving back as a mentor to startups at Stanford, (StartX, Alchemist) UCSF, and Techstar. I am also a frequent speaker and moderator at AI and healthcare events. My mission is to make responsible, equitable medical AI an operational reality and accessible to as many providers and patients as quickly as possible.